US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2027 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004 (with Full-Scan image)
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores (with Full-Scan image)
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores (with Full-Scan image)
KD2084, Renal disease spectrum tissue array, with stage and TNM info, 104 cases/208 cores (with Full-Scan image)
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores (with Full-Scan image)
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores (with Full-Scan image)
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores (with Full-Scan image)
BR10010a, Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases/100 cores, replacing BR10010 (with Full-Scan image)
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c (with Full-Scan image)
BR2082, Breast disease spectrum (breast cancer progression) tissue array, 206 cases/208 cores (with Full-Scan image)
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores (with Full-Scan image)
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a (with Full-Scan image)
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725 (with Full-Scan image)
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b (with Full-Scan image)
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b (with Full-Scan image)
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a (with Full-Scan image)
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data (with Full-Scan image)
ME1003, Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004 (with Full-Scan image)
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a (with Full-Scan image)
FDA808a, FDA normal and tumor organ tissue array of human (2 slide set), replacing FDA808, 144 cases/144 cores, for FDA guidelines to test tissue specificity of antibodies, replacing FDA808

Newly added tissue microarrays in recent month:

2014-09-01 HLiv-HCC180Sur-02, Hepatocellular carcinoma tissue array (90 cases) and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 BR487a, Triple negative breast cancer tissue array, including TNM, clinical stage and pathology grade, majority cases with negative of ER, PR, Her-2 in IHC, 48 cases/ 48 cores, replacing BR487
2014-09-01 PA807, Pancreatic cancer tissue array, with cancer adjaceent tissue and normal tissue as control, including TNM, clinical stage and pathology grade, 80 cases/ 80 cores
2014-09-01 HPan-Ade180Sur-01, Pancreatic cancer tissue array, 90 cases of and matched normal adjacent tissue (NAT, 1 core/case), with survival data
2014-09-01 HRec-Ade180Sur-01, Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data
2014-09-01 HCol-Ade180Sur-03, Colon cancer tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 HGEj-Ade130Sur-01, Gastroesophageal junctional cancer tissue array, 65 cases and matched normal adjacent tissue, with survival data
2014-09-01 HLiv-HCC180Sur-03, Liver cancer tissue array (90 cases) and normal adjacent tissue (NAT), 1 core/case, with survival data
2014-09-01 HLug-Ade150Sur-02, Lung adenocarcinoma tissue array (75 cases) and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 HLug-Squ150Sur-02, Lung squamous cell carcinoma tissue array (75 cases) and matched normal adjacent tissue (NAT, 1 core/case), with survival data
2014-09-01 HRaU-Uro120Sur-01, Renal pelvis carcinoma and ureter carcinoma tissue array, 120 cases, 1 core/case, with survival data
2014-09-01 HRec-Ade180Sur-02, Rectal cancer tissue array (90 cases) and matched normal adjacent tissue, with survival data
2014-09-01 HStm-Ade167Sur-01, Stomach cancer tissue array (92 cases) and matched normal adjacent tissue, with survival data
2014-09-01 HStm-Ade178Sur-01, Stomach cancer tissue array (111 cases). 67 cases have tumor and matched (NAT), with survival data
2014-09-01 HStm-Ade180Sur-04, Stomach cancer tissue array, 90 cases, tumor and matched normal adjacent tissue (NAT), with survival data
2014-09-01 HEso-Squ172Sur-01, Esophageal squamous cell ccancer tissue array (86 cases), 78 cases have tumor and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 HEso-Squ172Sur-02, Esophageal squamous cell cancer tissue array (93 cases), 79 cases have tumor and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 HCol-Ade180Sur-04, Colon cancer tissue array 90 cases of tumor and matched normal adjacent tissue, respectively (1 core/case)
2014-09-01 HKid-CRC180Sur-01, Kidney clear cell carcinoma tissue array, 90 cases of tumor and matched normal adjacent tissue (1 core/case), with survival data
2014-09-01 HStm-Ade180Sur-02, Stomach cancer tissue array, 90 cases, tumor and matched normal adjacent tissue, with VEGF and survival data.